Search tips
ESCMID Global 2024
Courses & Events
Guidelines
From the archive: ECCMID and more before 2010
Search Results
Sort by:
Filter 0
Sort by
Filter
Sort by
Relevance
Date descending
Date ascending
17 September 2024 - EA047
Efficacy and safety of gepotidacin for uncomplicated urinary tract infection: pooled subgroup analyses of the EAGLE-2 and EAGLE-3 randomised Phase 3 trials
Thomas M. Hooton, Caroline Perry, Salim Janmohamed, Amanda J. Sheets, Jeremy Dennison, Helen Millns, Emily Jarvis, Chun Huang
17 September 2024 - EA048
Impact of regulatory guidelines on therapeutic, clinical, and microbiological success rates in uncomplicated urinary tract infection: results from two Phase 3 randomised controlled trials of oral gepotidacin (EAGLE-2 and EAGLE-3)
Florian Wagenlehner, Caroline Perry, Thomas M. Hooton, Nicole E. Scangarella-Oman, Helen Millns, Emily Jarvis, Jeremy Dennison, Amanda Sheets, Salim Janmohamed
30 April 2024 - LB024
Exploring the efficacy of plasma exchange therapy in post-COVID-19 condition: a pilot randomised double-blind trial
Sergio España-Cueto, Cristina López, Cora Loste, Gemma Lladós-Bertran, José Ramón Santos, Gemma Dulsat, Anna García, Júlia Carabia, Águeda Ancochea, Anna Sánchez, Ivonne Graciela Parraga, Anna Chamorro, Alba San José, Elena Abad, José A. Muñoz, Anna Prats, Joao Pedro Carmezim, Cristian Tebe, M. Carmen Rodríguez, Roser Coll, Carla Estany, Jordi Puig, Bonaventura Clotet, Marta Massanella, Roger Paredes, Lourdes Mateu Prunonosa,
30 April 2024 - LB041
Short-course aminoglycosides as adjunctive treatment in adults with sepsis: a cluster randomised trial
Eva Koekenbier, Sharon Van Den Eijnde, Paul Van Der Linden, Jan Jelrik Oosterheert, Marc Bonten, Cornelis H. Van Werkhoven
30 April 2024 - P3958
Randomised experiment of recruitment letter strategies to maximise clinical trial enrollment: insights from the DANFLU-2 trial
Niklas Dyrby Johansen, Daniel Modin, David Preiss, Marion Mafham, Matthew M. Loiacono, Rebecca Harris, Robertus Van Aalst, Marine Dufournet, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Brian L. Claggett, Scott D. Solomon, Martin J. Landray, Gunnar H. Gislason, Lars Køber, Pradeesh Sivapalan, Jens-Ulrik Stæhr Jensen, Cyril Jean-Marie Martel, Tyra Grove Krause, Tor Biering-Sørensen
30 April 2024 - LB030
Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea: results of a randomised, multicentre Phase 3 trial (EAGLE-1)
Jonathan Ross, Kimberly A. Workowski, Sally Gatsi, William Flight, Nicole Scangarella-Oman, Charles Jakielaszek, Dan Lythgoe, Marcy Powell, Salim Janmohamed, Caroline Perry
30 April 2024 - LB049
Olgotrelvir as a standalone treatment for non-hospitalised COVID-19 patients: a Phase III, double-blind, randomised, placebo-controlled trial
Rongmeng Jiang, Bing Han, Wanhong Xu, Xiaoying Zhang, Chunxian Peng, Qiang Dang, Wei Sun, Ling Lin, Yuanlong Lin, Lingyan Fan, Dongqing Lv, Lei Shao, Ying Chen, Yunqing Qiu, Limei Han, Weixiang Kong, Guangming Li, Kai Wang, Jie Peng, Bingliang Lin, Zhaowei Tong, Xiaobo Lu, Lifang Wang, Feng Gao, Jiemei Feng, Yongxia Li, Xiaojun Ma, Jinxiang Wang, Shanbo Wang, Wei Shen, Chao Wang, Kuan Yan, Zhenhao Lin, Can Jin, Long Mao, Jia Liu, Henry Ji, Xiao Xu, Hongzhou Lu
30 April 2024 - E1212
Exclusive oral antibiotic treatment for hospitalised community-acquired pneumonia: a secondary analysis of a randomised clinical trial
Aurélien Dinh, Clara Duran, Laurène Deconinck, Morgan Matt, Ruxandra Calin, Victoire De Lastours, Véronique Delcey, Sylvain Diamantis, Virginie Vitrat, Yann-Erick Claessens, Philippe Aegerter, Anne-Claude Crémieux
30 April 2024 - LB046
Immunogenicity and reactogenicity of fractional vs full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, Phase 4 clinical trial in Brazil
Marco Antônio Puga, Roberto Oliveira, Patricia Vieira, Vivek Charu, Haley Hedlin, Di Lu, Amy Zhang, Blake Shaw, Joelle Rosser, Jessica Seidman, Alice Carter, Farah Qamar, Stephen Luby, Denise Garrett, Julio Croda,
30 April 2024 - O1180
Efficacy and safety of ibezapolstat compared with vancomycin for the treatment of Clostridioides difficile infection: a Phase II, randomised, double-blind study
Kevin Garey, M. Jahangir Alam, Khurshida Begum, Jacob Mcpherson, Taryn Eubank, Michael Silverman
30 April 2024 - LB052
Prolonged awake prone positioning vs usual care for non-intubated patients with COVID-19-related acute respiratory failure: a multi-centre, randomised controlled trial
Ling Liu
30 April 2024 - LB034
A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among older adults: the NUDGE-FLU-2 trial
Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S. Bhatt, Safia Chatur, Daniel Modin, Brian L. Claggett, Kira Hyldekær Janstrup, Carsten Schade Larsen, Lykke Larsen, Lothar Wiese, Michael Dalager-Pedersen, Lars Køber, Scott D. Solomon, Pradeesh Sivapalan, Jens-Ulrik Stæhr Jensen, Cyril Jean-Marie Martel, Tyra Grove Krause, Tor Biering-Sørensen
30 April 2024 - P3231
Comparing inhaled colistin with inhaled fosfomycin/tobramycin as an adjunctive treatment for ventilator-associated pneumonia: an open-label randomised controlled trial
Atousa Hakamifard, Abbas Ali Torfeh Esfahani, Alireza Homayouni, Farzin Khorvash, Behrooz Ataei, Saeed Abbasi
30 April 2024 - P3218
Protocol for the Hospital Acquired Pneumonia PrEveNtion (The HAPPEN study): a multi-centre randomised control trial exploring the effectiveness of improving the frequency and quality of oral care, in reducing the incidence of pneumonia
Brett Mitchell, Phil Russo, Helen Rawson, Peta Tehan, Katrina Browne
30 April 2024 - O1177
Oral zoliflodacin is non-inferior to a combination of ceftriaxone and azithromycin for treatment of uncomplicated urogenital gonorrhoea: results of a large global Phase III randomised controlled trial
Alison Luckey, Helen Broadhurst, Pierre Daram, Sinead Delany-Moretlwe, Henry J. C. De Vries, Rossaphorn Kittiyaowamarn, Drew Lewis, John P. Mueller, Seamus O'Brien, Mary-Ann Richardson, Subasree Srinivasan, Stephanie N. Taylor, Magnus Unemo, Edward W. Hook Rd
30 April 2024 - LB028
Impact of ceftriaxone+ sulbactam+ EDTA combination in treatment of metallo beta-lactamase producing Enterobacterales causing complicated urinary tract infections: an open label randomised controlled trial
Subhashree Samantaray, Deepak Kumar, Durga Shankar Meena, Gopal Krishana Bohra, Vibhor Tak, Gautam Ram Chaudhary, Ankur Sharma, Mahendra Kumar Garg
30 April 2024 - E1284
Multiplex real-time PCR plus conventional microbiological testing vs conventional microbiological testing alone to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, open-label trial
Gabriela Abelenda-Alonso, , Laura Calatayud, Alexander Rombauts, Yolanda Meije, Isabel Oriol-Bermúdez, Nieves Sopena, Ariadna Padullés Zamora, Jordi Niubó, Alejandra Duarte, Jaume Llaberia, Judit Aranda, Carlota Gudiol, Pau Satorra, Cristian Tebé, Carmen Ardanuy, Jordi Carratalà
29 April 2024 - P1847
Is cefepime safe to treat infections caused by Escherichia coli or Klebsiella pneumoniae that display an ESBL phenotype? Results from a systematic review and meta-analysis of clinical studies
Desy De Lorenzis, Benedetta Falasca, Giulia Menchinelli, Emanuele Rando, Maurizio Sanguinetti, Brunella Posteraro, Rita Murri, Giulia De Angelis,
29 April 2024 - P1811
Risk factors and outcomes of linezolid- and vancomycin-resistant E. faecium infections: a case-control study
Flavio Sangiorgi, Emanuele Rando, Giulia Micheli, Francesca Giovannenze, Eleonora Taddei, Giulia De Angelis, Barbara Fiori, Massimo Fantoni, Rita Murri,
29 April 2024 - P3112
Tick-borne encephalitis seroprevalence in Northern Italy: a cross-sectional study on a randomly selected population
Antonella Castagna, Stefania Schiavon, Giulio Mengozzi, Tatjana Baldovin, Silvia Nozza, Diana Canetti, Silvia Cocchio, Matteo Morandi, Eva Agostina Montuori, Raffaella Iantomasi, Vincenzo Baldo
Loading ...
+ load more
FAQ
To access content in the Library you need to log in with your ESCMID member or user credentials. If you haven’t registered as an ESCMID member yet, then click here to do so – or use this link to register as a user.
The most recent event-related content is usually restricted to ESCMID members, while registered users get access one year after the event. However, there are events such as ESCMID Global where attendees get priority access, no matter if they are members or registered users. In these cases, we may offer non-attendees access after paying a fee.
You may search by event name, session title or number, topic title or number or author – or by any keyword. To get the most relevant results, enter the title or name in quotation marks, e.g. "Pre-ECCMID Day on Diagnostics" or "John Doe". If no quotation marks are used, then the exact result is shown first, followed by less exact results.
You may further narrow the number of search results for most terms by applying one or several filters, using the filter window on the start page. The Category and Media Type filters work for any content. In contrast, the Date from / to filter may not apply for Publications and Guidelines. In addition, the information text below a webcast or document offers the option of filtering search results by session title, author, event or category.
We defined four "hot topic" terms that you may search for by clicking the four tiles on the start page.
Linking two or more search terms by AND will show all results containing these search terms. For example, if you are looking for results that contain both the terms viral and hospital, then enter viral AND hospital.
Link two or more search terms by OR to get all results that contain at least one of these terms. For example, if you want to get results that contain either viral or infections or COVID, then enter viral OR infections OR COVID.
Place + in front of the term that you want to be included in your search result and place - in front of the term that you do not want to be included – without blanks in between in either case. For example, if you are aiming for search results that contain viral and infection but do not contain COVID, then enter +viral +infections -COVID.
A search term preceded by an exclamation point (no blanks in between) will lead to all content that does not contain the term, e.g. !COVID.
Deselect the ticked boxes in the filter dropdowns, click "Clear" on the calendars in the Date from / to filter – or refresh the website to remove all filters at once. Additionally, you may clear all applied filters by using the relevant buttons right above the search results.
No, as copyright protection limits the viewing of video presentations to web browsers, they cannot be downloaded.
No, due to our privacy policy we cannot disclose any contact details of persons involved.